What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Nuclear medicine, Positron emission tomography, Radiology, Carcinoma and Radiation therapy.
Farrokh Dehdashti does research in Nuclear medicine, focusing on Fluorodeoxyglucose specifically.
The Fluorodeoxyglucose study combines topics in areas such as Survival rate, Internal medicine, Cervical cancer and Oncology.
Farrokh Dehdashti has included themes like Cancer, Cervix, Tumor hypoxia, Esophagectomy and Tomography in his Positron emission tomography study.
His Radiology research is multidisciplinary, relying on both Recurrent Colorectal Carcinoma, Colorectal cancer, Esophageal cancer and Adenocarcinoma.
His Radiation therapy research is multidisciplinary, incorporating perspectives in Neuroendocrine tumors, Scintigraphy, Fiducial marker and Dosimetry.
His most cited work include:
- Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). (513 citations)
- Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. (486 citations)
- A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy (388 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Radiology, Positron emission tomography, Nuclear medicine, Internal medicine and Oncology.
The various areas that Farrokh Dehdashti examines in his Radiology study include Cervical cancer, Prospective cohort study, Carcinoma and Metastasis.
His research investigates the connection between Positron emission tomography and topics such as Pathology that intersect with problems in Cancer research.
His research in Nuclear medicine intersects with topics in Lung cancer and Radiation therapy.
His studies deal with areas such as Gastroenterology, Endocrinology, Fdg uptake and Surgery as well as Internal medicine.
His Oncology research incorporates elements of Locally advanced and Chemotherapy.
He most often published in these fields:
- Radiology (43.93%)
- Positron emission tomography (42.06%)
- Nuclear medicine (37.85%)
What were the highlights of his more recent work (between 2014-2021)?
- Positron emission tomography (42.06%)
- Radiology (43.93%)
- Internal medicine (31.31%)
In recent papers he was focusing on the following fields of study:
Positron emission tomography, Radiology, Internal medicine, Nuclear medicine and Oncology are his primary areas of study.
Farrokh Dehdashti works on Positron emission tomography which deals in particular with Fluorodeoxyglucose.
His Radiology research incorporates themes from Cervical cancer, Disease and Lymph node.
He works mostly in the field of Internal medicine, limiting it down to topics relating to Standardized uptake value and, in certain cases, Tissue microarray and Chemoradiotherapy, as a part of the same area of interest.
When carried out as part of a general Nuclear medicine research project, his work on Dosimetry is frequently linked to work in Chin, therefore connecting diverse disciplines of study.
His work in Oncology covers topics such as Chemotherapy which are related to areas like Hematopoietic stem cell transplantation, Radioimmunotherapy and Pre targeting.
Between 2014 and 2021, his most popular works were:
- Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging (61 citations)
- [ 89 Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer (56 citations)
- Gold Nanoclusters Doped with 64Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis (36 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Farrokh Dehdashti spends much of his time researching Positron emission tomography, Internal medicine, Radiology, Breast cancer and Magnetic resonance imaging.
His Positron emission tomography study is concerned with Nuclear medicine in general.
His Nuclear medicine research includes themes of Effective diffusion coefficient, Prospective cohort study and Diffusion MRI.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
His work on Imaging modalities, Fdg pet ct and Pet mr imaging as part of his general Radiology study is frequently connected to Modalities, thereby bridging the divide between different branches of science.
The study incorporates disciplines such as Immunohistochemistry and Cancer research in addition to Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
